首页> 外国专利> TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF

机译:用于治疗新型冠状病毒肺炎的中药组合物,制备方法,检测方法及其用途

摘要

Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition. The preparation method provided in the present disclosure improves the content and transfer rate of hesperidin in the traditional Chinese medicine composition. By means of the proportion of the raw materials, the traditional Chinese medicine composition provided in the present disclosure has few side effects and can be used for treating cold dampness diseases, and in particular, has a very good effect when treating novel coronavirus pneumonia.
机译:本公开内容是一种用于治疗新型冠状病毒肺炎的中药组合物,一种制备方法,检测方法及其用途。中药组成主要由以下原材料中的重量份:250-400份Citri Teiculatae Pericarpium,100-200份Atractylodis Rhizoma,100-200份Magnoliae Officinalis Cortex,200-300份Glycyrrhizae Radix et Rhizoma,200-300份Agastacht Rugosus,200-300份ACORI Tatarinowii Rhizoma,250-330份Jujubae Fructus,100-200份Zingiberis Rhizoma再次入门。本公开中还提供了一种用于中药组合物的制备方法和检测方法。本公开中提供的制备方法改善了橙皮蛋白在中药组合物中的含量和转移率。通过原料的比例,本公开中提供的中药组合物具有很少的副作用,并且可用于治疗冷湿疾病,特别是在治疗新型冠状病毒肺炎时具有很好的效果。

著录项

  • 公开/公告号WO2021223397A1

    专利类型

  • 公开/公告日2021-11-11

    原文格式PDF

  • 申请/专利权人 BEIJING HANDIAN PHARMACEUTICAL CO. LTD.;

    申请/专利号WO2020CN128753

  • 发明设计人 LIN DELIANG;

    申请日2020-11-13

  • 分类号A61K36/9068;A61K47/69;A61P11;A61P31/14;G01N30/90;G01N30/02;

  • 国家 CN

  • 入库时间 2022-08-24 22:29:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号